Brief: Xspray Pharma Q4 Operating Loss Widens To SEK 10.5 Million

Xspray Pharma publ AB

14/02/2019 07:13

Feb 14 (Reuters) - XSpray Pharma AB (publ)  XSPRAY.ST :
    * Q4 OPERATING LOSS SEK 10.5 MILLION VERSUS LOSS SEK 5.0
MILLION
YEAR AGO
    * BOARD RESOLVED TO PROPOSE TO THE AGM THAT NO DIVIDEND BE
PAID TO
SHAREHOLDERS IN 2019

Source text for Eikon:  ID:nWkrj8hH2 
Further company coverage:  XSPRAY.ST 

 (Gdynia Newsroom)
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))